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Abstract 
We have used confocal laser scanning microscopy to determine the dynamics of distribution of activated protein kinase C (PKC) in 
living Madin Darby canine kidney (MDCK) cells. Using fluorescently tagged phorbol myristate acetate (PMA) as a probe for PKC we 
have demonstrated its distribution in association with the cell periphery and with the nucleus. Dual labeling experiments using PKC~ and 
PKCI3II specific antisera indicate that activated PKCa is found in association with the periphery whereas activated PKCI3II is 
translocated to the nucleus. We have demonstrated increased activity of PKC in nuclear fractions isolated from cells treated with PMA 
and other PKC activators. These data indicate that upon activation individual isoforms of PKC translocate to different subcellular 
locations where they are likely to mediate different actions. 
Keywords: Protein kinase C; Dis~Lribution dynamics; Confocal laser scanning microscopy; Phorbol myristate acetate; (Madin Darby canine kidney cell) 
I. Introduction 
Protein kinase C (PKC) is a serine-threonine protein 
kinase which is a critical mediator of extracellular signal 
transduction. PKC has been implicated in a variety of 
functions including cell growth and differentiation, gene 
transcription, secretion andL contraction [1,2]. The classical 
model of PKC activation invokes a scenario whereby 
diacylglycerol, produced by agonist mediated phospholipid 
hydrolysis activates the enzyme, inducing a conformational 
change [3], thereby facilitating its binding to phospholipid 
cofactors and to calcium [4]. Tumor promoting phorbol 
esters such as phorbol 12,13-myristate acetate (PMA) can 
substitute for diacylglycerol as activators of PKC. 
Despite extensive investigation many of the cellular 
mechanisms whereby PKC affects its responses are unre- 
solved. Cell fractionation studies have suggested transloca- 
tion of the enzyme from the cytosolic to the particulate 
Abbreviations: BODIPY-PMA, 12et-(4,4-difluro-5,7-dimethyl-4-bora- 
3a,4a-diaza-3-indacenedodecanoyl); MDCK, Madin Darby canine kidney; 
4etPDD, 4ot-phorbol didecanoate; PKC, protein kinase C; PMA, phorbol 
12-rnyristate 13-acetate. 
* Corresponding author. Fax: + 1 (619) 5346833. 
fraction in response to elevated cellular diacylglycerol (or 
phorbol ester stimulation) [5] and or to calcium [6]. Com- 
parable data has been generated by immunocytochemical 
staining of fixed cells showing plasma membrane associ- 
ated PKC in phorbol ester stimulated cells [7]. As PKC 
activation is dependent on lipids its translocation to the 
particulate fraction has been assumed to reflect its plasma 
membrane association upon activation [8]. However, if the 
activated kinase is restricted to the plasma membrane this 
presents a dilemma as to how it can phosphorylate non- 
membrane associated proteins such as its putative cytosolic 
and nuclear substrates and, inevitably, how the plasma 
membrane associated protein kinase can regulate events 
within discrete intracellular compartments. 
The aim of the work presented here was to characterize 
the dynamic spatial distribution of activated PKC in living 
cells. We have used time-lapse confocal imaging of PKC 
distribution in Madin Darby canine kidney (MDCK) cells 
stimulated with fluorescently tagged phorbol esters. Our 
data show specific distribution of PKC in plasma mem- 
brane and nuclear compartments. We have demonstrated 
the differential subcellular localization of specific PKC 
isoforms using double-labeling with fluorescent phorbol 
esters and PKC-isoform specific antibodies. We demon- 
strate that PKC activation by phorbol ester is associated 
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with increased phosphorylation of both exogenous and 
endogenous substrates in nuclear fractions. 
2. Materials and methods 
2.1. Materials 
12 c~-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-3- 
indacenedodecanoyl)-phorbol- 13[3-acetate (BODIPY-C12 
phorbol acetate, excitation wavelength 503 nm, emission 
512 nm) (BODIPY-PMA) and antirabbit BODIPY 
horseradish peroxidase conjugated antibody were pur- 
chased from Molecular Probes, Portland, OR. Biotinylated 
goat-antirabbit, biotinylated horse-antimouse and avidin- 
horseradish peroxidase secondary antibodies and Texas red 
were all purchased from Vectra Laboratories, Burlingame, 
CA. [-/-32p]ATP (3000 Ci/mmol) was purchased from 
DuPont NEN. Purified PKC (2.1 U/mg)  was obtained 
from Calbiochem (La Jolla, CA). Phosphatidylserine was 
purchased from Avanti Polar Lipids, Birmingham, AL. All 
other reagents were obtained from Sigma unless otherwise 
indicated. PKCa- and [3II-specific antibodies were a gen- 
erous gift of Dr. Tsunao Saitoh, Dept. of Neuroscience, 
UCSD [9]. Anti-Lamin specific antisera was obtained from 
Dr. Larry Gerace, Scripps Clinic, La Jolla, CA. B-23 
monoclonal antibodies were obtained from Dr. Piu-Kwa 
Chan, Baylor College of Medicine, Houston, TX. Bryo- 
statin was obtained from Dr. George R. Pettit, University 
of Arizona. 
2.2. Methods 
MDCK-D1 cells were cultured as previously described 
[10]. For confocal imaging experiments cells were cultured 
on poly-L-lysine (Gibco-BRL)-coated glass coverslips. 
2.2.1. Dynamic confocal imaging of BODIPY-PMA distri- 
bution 
MDCK cells on glass coverslips were attached to a 35 
mm Petri dish with an opening in the bottom. The dish was 
mounted in a custom made chamber installed on the stage 
of an Axiovert microscope. The chamber was attached to a 
temperature controlled water circulation system. The cells 
were thus maintained at 37°C throughout the experimental 
monitoring. The cells were washed twice with HBSS and 
baseline fluoresence (undetectable) recorded for 3-5 min 
before the addition of BODIPY-PMA (final concentration 
100 riM). BODIPY-PMA distribution in the cells was 
monitored using a BIORAD MRC 600 (Watford, UK) 
scanning confocal microscope mounted on a Zeiss Ax- 
iovert microscope. The distribution of fluoresence through- 
out the cells was followed as a function of time. Images 
were recorded at one minute intervals for at least 45 min. 
Quenching of fluoresence was minimized using optical 
disc stored digitized video images for subsequent displays, 
analysis and quantification. The aperture, back and gain 
levels were manually adjusted to obtain images with a 
pixel intensity within a linear range. Cells were viewed 
with a 63 X Nikon oil immersion lens. 
Specificity of the BODIPY PMA fluoresence was ascer- 
tained by pretreatment of the cells for 30 min with either 1 
IxM PMA or 1 IxM 4a-phorbol didecanoate (4a PDD) or 
vehicle (0.01% ethanol) before the addition of BODIPY- 
PMA (final concentration 100 riM) to the cells. 
2.2.2. Double-labeling experiments 
In order to determine the relative distribution of specific 
PKC isoforms and BODIPY-PMA fluoresence, cells cul- 
tured on coverslips were treated with BODIPY-PMA ex- 
actly as described above. After 30 min at 37°C cells were 
washed twice with PBS, fixed in 2% paraformaldehyde 
PBS for 30 min and permeabilized with 3% H202 in PBS 
for 20 rain. After washing with PBS the cells were incu- 
bated with blocking solution containing 5% normal goat 
serum 1% BSA in PBS for 2 h at room temperature. 
Blocking solution was removed and the cells incubated 
with primary anti-sera in a humidified atmosphere at 4°C 
overnight (PKCc~ (1:100), and PKC[3II (1:75)) diluted 
with blocking buffer. After washing with PBS the cells 
were incubated with goat-antirabbit biotinylated antibody 
(1:100) for 1 h. Following washing cells were incubated 
with avidin-Texas red for 1 h at room temperature fol- 
lowed by several washes with PBS. The coverslip-contain- 
ing slides were mounted in anti-fade media (0.4% n- 
propylgallate in glycerol-PBS). Distribution of the labels 
was determined with a confocal aser scanning microscope 
as described above. This system permits simultaneous 
analysis of double-labeled samples in the same optical 
plane. To control for non-specific staining with the pri- 
mary antibodies parallel experiments were performed us- 
ing anti-sera preadsorbed by incubation with excess anti- 
genic peptide (20 txg/ml) [9]. As a further control non- 
specific binding of the secondary antibody was determined 
by omission of the primary antisera. 
2.2.3. Subcellular distribution of PKC 
2.2.3.1. Immunoblot of PKC distribution. MDCK cells 
were treated with either 100 nM PMA or vehicle (0.1% 
DMSO) for 30 min at 37°C. After washing with PBS the 
cells were scraped into hypotonic buffer consisting of 20 
mM Tris, 2 mM EDTA, 10 mM EGTA, 1 mM phenyl- 
methylsulfonylfluoride, 20 IxM leupeptin, 20 IxM apro- 
tinin, 0.1% 2-mercaptoethanol, pH 7.5 (buffer A), and 
subjected to 15 passes of a Potter-type Teflon-on-glass 
homogenizer. The homogenate was centrifuged at 500 x g 
for 5 rain. The resulting pellet was resuspended in buffer A 
and layered onto a 200 ~1 sucrose cushion (50% w/v)  in 
buffer A and centrifuged for 1 minute at 15 000 × g. The 
nuclei pelleted through the cushion were resuspended in
buffer A. Purity of the nuclei was verified by electron 
microscopy and by assay of marker enzymes. 
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100 ~g of protein/lane was applied to a 10% SDS- 
PAGE gel and the resolved proteins were transferred to 
Immobilon-P (Millipore, Bedford, MA). After blocking 
non-specific sites membranes were incubated with anti- 
PKC et and anti-PKC [3 specific antisera (Santa Cruz 
Biotechnology, Santa Cruz, CA). Specifically bound anti- 
body was detected with horseradish peroxidase-conjugated 
protein A using enhanced Chemiluminescence (Amersham, 
Arlington Heights, IL). 
2.2.3.2. PKC activity assay. MDCK ceils (150 mm 
plate/condition) were treated with either 100 nM BOD- 
IPY PMA, 100 nM PMA, 100 nM phorbol didecanoate or
vehicle (0.01% ethanol) for 30 min at 37°C, washed with 
PBS and fractionated as follows: after rinsing briefly with 
water cells were lysed by 15 min incubation at 4°C in 
buffer containing 20 mM Hepes, pH 7.4, 5 mM KC1, 5 
mM MgCI 2, 2 mM DTT, 0.1 mM EDTA, 1 mM EGTA, 
50 mM NaF, 2 mM PMSF and 0.2% Nonidet P-40 and 
trituration by 20 passes through a 25 gauge needle. Nuclei 
were harvested by centrifuging at 1000 × g for 5 min at 
4°C. The supernatant fraction, designated S1, was retained 
and the nuclear pellet washed again and harvested in lysis 
buffer as described above. The supernatant fraction, desig- 
nated $2, from this procedure was also retained. The 
integrity of the final nuclear fraction (N) was checked by 
phase contrast microscopy The nuclear fraction was solu- 
bilized by incubation in 20 mM Tris HC1, pH 7.5, 20 mM 
EGTA, 2 mM EDTA, 2 mM DTT, 1% NP-40. PKC 
activity in all fractions (S1, $2 and N) was partially 
purified by DEAE-Sephacel chromatography. The relative 
distribution of PKC activity in the fractions was deter- 
mined by measuring phosphatidylserine- and diacylglyc- 
erol-dependent phosphorylation of lysine-rich histone as 
we have previously described [10]. 
2.2.3.3. Phosphorylation of endogenous nuclear sub- 
strates. Nuclei were prepared from cells stimulated with 
PMA or treated with vehicle as described above. The 
nuclear pellet was resuspended in 20 mM Hepes, pH 7.4, 5 
mM KC1, 5 mM MgC12, 5 mM DTT, 0.1 mM EDTA, 1 
mM EGTA, 50 mM NaF', 2 mM PMSF and digested at 
4°C for 60 min with RNase A and DNase A (both at a 
final concentration of 100 txg/ml) [11] before harvesting 
at 1000 × g. Isolated nuclei were incubated in reaction 
buffer containing 20 mM Tris HC1, pH 7.4, 20 mM 
MgC! 2, 1 mM CaCI2, 10 IxM sodium orthovanadate, 10
mM NaF and 10 ixM ~/~2p-ATP (Ci/pmol) in the pres- 
ence or absence of phosphatidylserine and diacylglycerol 
(final concentrations 60 Ixg/txl and 6 ~zg/t~l, respec- 
tively). Purified rat brain PKC was added to one set of 
nuclei prepared from untreated cells. After 15 rain at 30°C 
phosphorylation was terminated by the addition of SDS- 
PAGE sample buffer [12] and incubation of the samples at 
95°C for 5 min. Proteins were resolved on a 0.75 mm 
SDS-PAGE before transferring to nitrocellulose. Loading 
of approximately equivalent amounts of protein per lane 
was verified by Ponceau S staining of the nitrocellulose 
membrane. Following autoradiography the positions of 
Lamins A, B and C were detected by Western blotting 
with anti-lamin specific antisera [11]. Specific lamins were 
detected using an alkaline phosphatase conjugated sec- 
ondary antibody (BIORAD). 
3. Results and discussion 
The principal aim of the work presented in this paper 
was to characterize the subcellular distribution of PKC in 
living cells. We have studied the distribution of activated 
PKC by imaging fluorescently tagged PMA (BODIPY- 
PMA) in MDCK cells using confocal scanning laser mi- 
croscopy. By employing optical sectioning in conjunction 
with laser Nomarski time lapse imaging we have followed 
the distribution of the fluorescently abeled phorbol ester 
within these cells. The high quantum yield of BODIPY, its 
relative resistance to photobleaching and low environmen- 
tal sensitivity make it suitable for the live imaging experi- 
ments described here. 
Using BODIPY-PMA we determined PKC distribution 
in MDCK cells as a function of time. BODIPY-PMA was 
used at a final concentration 100 nM. This was found to 
give optimal fluoresence in our system on testing a range 
of concentrations l0 nM-I  IxM (data not shown). Basal 
fluoresence (undetectable) was recorded for 3 min before 
the addition of BODIPY PMA. After 5 min fluoresence at 
the cell periphery was observed. This increased in intensity 
with time up to a maximum at 30 min, remaining un- 
changed in intensity and location up to 45 min. By this 
time intracellular fluoresence was also observed, especially 
in the perinuclear region. After 25 min fluoresence was 
also observed in a streaming pattern across the cell nucleus 
in many cells. This time-course of redistribution is shown 
in Fig. 1A-D. The characteristic nuclear staining which 
we have observed after 25-40 min of BODIPY-PMA 
treatment is shown in the images in Fig. 1E-H. The 
nuclear fluorescence was excluded from the nucleoli which 
were visible in the Nomarski images. This was further 
confirmed by immunostaining with antisera to the nucleo- 
lar specific protein B-23 (data not shown). To determine 
the specificity of BODIPY-PMA as a tag for intracellular 
PKC in this system we pretreated MDCK cells for 30 min 
with either 1 p~M PMA or with 1 ~zM 4 aPDD an inactive 
phorbol ester which does not bind PKC. Pretreatment with 
PMA completely abolishes PMA-BODIPY fluoresence 
(Fig. l I - J )  whereas pretreatment with 4a PDD is without 
an effect on either the kinetics or the magnitude of the 
response to BODIPY-PMA (Fig. 1K-L). Using BODIPY- 
PMA in vascular smooth muscle cells others have dis- 
counted possible non-specific intracellular diffusion of the 
fluorescent moiety by the differential distribution of BOD- 
IPY-PMA compared to that of 7 decyl-BODIPY-propionic 
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acid, a membrane specific marker with comparable 
lipophilicity [13]. 
Thus, we have shown that activated PKC is distributed 
discretely through the cell a,; a function of time. Initially, 
we observed fluoresence at the cell periphery, consistent 
with the concept of PKC translocation to the plasma 
membrane by phorbol ester activation, analagous to activa- 
tion by diacylglycerol, produced in response to agonist 
mediated phospholipid hych'olysis. With increasing time 
we observed PKC distribution in the perinuclear region 
and subsequently within the; nucleus. Reports of nuclear 
PKC in the literature have been controversial. Nishizuka 
reported negative findings regarding nuclear PKC in rat 
brain [14]. Girard and coworkers demonstrated PKC asso- 
ciated with the perinuclear region of rat brain [15]. In rat 
embryo fibroblasts pecific nuclear PKC staining was not 
observed [16] whereas in parallel experiments nuclear 
membrane associated PKC in PMA stimulated NIH 3T3 
cells [17] and in thrombin s~Limulated fibroblasts [18] have 
been demonstrated. Reports of PKC in rat liver nuclei have 
been contradictory [19,20] Bryostatin but not phorbol ester 
stimulated translocation of PKC to the nuclear membrane 
has been found in HL-60 cells [21,22] whereas in fibrob- 
lasts and K562 cells both agents were reported to cause 
PKC translocation to the nuclear membrane [23]. 
We have consistently observed fiuoresence within the 
nuclei of BODIPY-PMA treated MDCK cells. Although 
this pattern might result from binding of activated PKC to 
the nuclear membrane, in ]preliminary experiments using 
immunoelectron microscopy we have observed intra- 
nuclear PKC which appears to be bound to chromatin (data 
not shown). As an alternatiive to the restrictive model of 
activated PKC binding solely to membrane lipids, 
Mochly-Rosen and colleagues have proposed specific, 
non-substrate peptide binding sites (RACKs) for the en- 
zyme which are found in Triton-X-100 insoluble fractions 
containing cytoskeleton and nuclei [24,25]. Cytoskeletal 
association of PKC has also been shown by others [26]. To 
date we do not know the nature of the interaction of PKC 
within the nucleus. It may be in part through the aforemen- 
tioned RACKs peptide sequences. Additionally, there are 
cysteine-rich zinc finger domains within the regulatory 
region of PKC. These sequences are a common motif in 
transactivating DNA binding proteins. Although direct 
binding of PKC to DNA has not been demonstrated, it is 
an attractive hypothesis given the effect of PKC in activat- 
ing a variety of target genes which contain specific phor- 
bol ester-responsive el ments in their 5' regulatory regions. 
Phosphorylation within the DNA binding domains and 
other key residues of transcription factors is an important 
mechanism for modulating ene expression through vari- 
ous protein kinases [27]. The activity of several eukaryotic 
transcription factors has heen shown to be altered on 
phosphorylation by PKC. Recent evidence suggests that 
the zinc finger domains of PKC are important in targeting 
specific inactive forms of PKC to the Golgi [28]. 
PKC is not a single protein but a family of proteins 
encoded by separate genes and linked through their regula- 
tory properties [2]. It is highly probable that different PKC 
isoforms are differentially activated and or mediate spe- 
cific events. One level at which differential activation 
might occur is through distinct spatial distribution of the 
kinases. Thus, it was of interest to us to investigate 
whether the discrete subcellular distribution of BODIPY- 
PMA was specific to particular PKC isoforms. To investi- 
gate this we performed ual-labeling experiments using 
isoform specific antisera (Fig. 2). We have previously 
demonstrated xpression of PKCot and 1311 in these cells 
[10]. Using isoform-specific antisera we have determined 
the subcellular localization of PKCtx and [311 following 
stimulation with 100 nM BODIPY-PMA as described 
above. These data show substantial PKCet at the cell 
periphery on BODIPY-PMA stimulation (Fig. 2B). The 
characteristic nuclear BODIPY PMA staining is not de- 
tected with the PKC-ot specific antibody (Fig. 2B) al- 
though evident in the BODIPY-PMA image of the same 
cells (Fig. 2C). As a control for the specificity of BOD- 
IPY-PMA as an activator of PKC we have observed a 
similar pattern of immunostaining with the PKCe~ antisera 
in cells treated with PMA (100 nM for 35 min) (data not 
shown) whereas in cells treated with 100 nM 4etPDD, 
PKCet distribution is more diffuse (Fig. 2A). Preadsorp- 
tion of PKCa antisera with antigenic peptide completely 
blocks fluorescence seen in antibody-treated cells (Fig. 2 
D). Thus we observed PKCet association predominantly 
with the cell periphery, a result consistent with our previ- 
ous data demonstrating its specific role in hormone and 
phorbol ester-mediated arachidonate r lease [10,29]. The 
PKC ot immunoreactivity appeared very intense in specific 
areas. MDCK cells are highly differentiated polarized ep- 
ithelia and the observed specificity of peripheral labelling 
of PKCet may suggest specific roles of this isoform in 
specialized functions. Although BODIPY-PMA fluores- 
cence was detected in all cells in any field, PKCa 
immunoreactivity was not. It is unlikely that this is due to 
unequal penetration of the antibody as anticytokeratin 
staining in similarly permeabilized cells was observed 
uniformly in a population (data not shown). These data 
suggest he heterogeneity of PKCct expression within a 
population of cells. 
The lack of nuclear PKCct staining observed in BOD- 
IPY-PMA treated cells was in contrast with the pattern 
observed in BODIPY-PMA cells double labeled with 
PKC13II antisera. Immunolocalization with PKC13II spe- 
cific antisera indicated a nuclear staining pattern essen- 
tially superimposable onthat observed with BODIPY-PMA 
(Fig. 2 F-G). Interestingly, in contrast to PKCot, PKC13II 
distribution appears relatively restricted in the cell periph- 
ery. The immunostaining pattern seen with BODIPY-PMA 
was also observed in PMA treated cells (data not shown) 
whereas in cells pretreated with 4e~ PDD staining was more 
diffusely distributed throughout the cell (Fig. 2E). Pread- 
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sorption of the PKC13II antisera with antigenic peptide 
blocked fluorescence seen in antibody treated cells (Fig. 
2H). 
The 13 form of PKC has been detected in rat liver nuclei 
[20] and translocation of PKC13 to the nuclear membrane 
has been shown [23]. Recent data have shown PKC13I in 
nuclei of hormone and phorbol ester stimulated cardiac 
myocytes [30]. Preferential activation of the 13 myosin 
heavy chain gene by constitutively activated PKC13 rela- 
tive to PKCa has been described [31]. Several groups 
[32-34] have reported a 57 kDa PKC immunoreactive 
protein in nuclear fractions of phorbol ester-treated cells. It 
has been speculated that this is a nuclear-permeable cofac- 
tor-independent form of PKC generated by proteolysis of 
the holoenzyme, analagous to the nuclear localized cat- 
alytic subunit of activated protein kinase A [35,36]. How- 
ever, in our double-label experiments we use probes for 
both the regulatory (BODIPY-PMA) and catalytic (iso- 
form-specific antibodies) domains of PKC. Since these 
probes yielded similar patterns, we discount he necessity 
for proteolysis of PKC preceding translocation to the 
nucleus. 
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Fig. 3. Subcellular distribution detected by immunoblotting and phosphorylation f exogenous and endogenous substrates. A: PKC distribution to the 
nuclear fraction was determined by Western blotting of cell homogenates (H) and nuclear preparations (N) from cells treated with vehicle (0.1% ethanol) 
or with 100 nM PMA, 37°C for 30 rain. as indicated. 100 Ixg of protein was loaded per lane of a 10% SDS-PAGE gel. The resolved proteins were 
transferred to Immobilon P and antiPKCI3 detected with a specific antibody. Qualitatively similar results have been obtained in two separate xperiments. 
B: Phospholipid and diacylglycerol dependent histone phosphotransferase ctivity was measured in supernatant and nuclear fractions from cells treated 
with vehicle (0.01% ethanol), PMA, BODIPY-PMA or 4aPDD as indicated. Data are expressed as % total activity recovered from the cells and are the 
mean ± SD of 4 individual experiments for vehicle, PMA and bryostatin treatment, and of a single experiment for 4e~PDD and BODIPY-PMA. All 
experiments were performed in triplicate. C: Phosphorylation f endogenous substrates in nuclei isolated from control and PMA treated (100 nM PMA, 30 
min) cells was measured by incubating the nuclei with [~-32 P]ATP in the presence or absence of phospholipid and diacylglycerol as indicated. After 10 
min incubation at 30°C the reaclion was stopped by the addition of SDS-PAGE sample buffer and proteins were seperated by electrophoresis before 
transferring to nitrocellulose. Phosphoprotems were detected by autoradiography. Using lamin specific antisera the positions of lamins A,B and C on the 
blot were determined and are indtcated by the arrowheads. To determine the potential role of PKC in the phosphorylations which we observed we added 
purified PKC to isolated nuclei from untreated cells (control + PKC as designated in the figure). Qualitatively similar data have been obtained in three 
seperate xperiments. 
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Active transport into the nucleus requires that proteins 
contain specific nuclear localization signals [37]. These are 
basic amino acid sequences occurring as a single motif, as 
typified by the large SV-40 middle T antigen or the more 
recently described bipartite signal which consists of two 
clusters of basic amino acids [38]. Comparison of the 
amino-acid sequence of PKC[3 and e~ reveals that, unlike 
PKCe~, PKC[3 contains a putative bipartite nuclear local- 
ization sequence [39]. However, the absolute significance 
of these sequences in targeting PKC distribution remains 
to be demonstrated. It has been proposed that activation of 
PKC exposes regions within the catalytic and hinge do- 
mains responsible for nuclear localization [40]. 
Unlike PKCot, PKC[3II distribution appeared to be 
excluded from the cell periphery in MDCK cells. This may 
explain its relative resistance to down-regulation by stimu- 
lation with phorbol ester [10], as it may be excluded from 
the intracellular compartment that contains the appropriate 
proteases as suggested for PKC ~ [41]. 
Immunoblotting of nuclei indicated the presence of 
PKCI3 following stimulation with PMA (Fig. 3A). (Al- 
though some PKCa was detected in the nuclear fraction 
this was insensitive to PMA treatment; data not shown) 
Having observed nuclear PKC on stimulation with BOD- 
IPY-PMA we investigated whether this phenomenon was 
due to translocation of the enzyme and/or whether it was 
localized within this compartment basally. Thus we as- 
sayed PKC activity by determining exogenous and endoge- 
nous substrate phosphorylation in nuclear fractions follow- 
ing stimulation of cells. The relative distribution of PKC 
activity in soluble and crude nuclear fractions from cells 
treated with either vehicle, PMA, BODIPY-PMA (100 
nM), bryostatin (100 nM) or 4e~PDD is shown in Fig. 3B. 
PMA and BODIPY-PMA increased PKC activity in the 
nuclear fraction relative to controls (ie. histone phospho- 
transferase activity in either vehicle or 4oLPDD-treated 
cells). The relative distribution of phospholipid and diacyl- 
glycerol dependent histone phosphotransferase ctivity in 
nuclear fractions increased from approx. 2% of total cell 
activity in control conditions to approx. 25% on stimula- 
tion with PMA or with BODIPY-PMA. (We also saw a 
similar increases in PKC activity in the nuclear fraction on 
stimulation with bryostatin). 
Endogenous nuclear substrates for PKC were investi- 
gated by isolating nuclei from either untreated cells or 
cells stimulated with PMA, labeling the nuclei with [~/- 
32 P]ATP and incubating the isolated nuclei in the presence 
or absence of phosphatidylserine and diacylglcerol. In- 
creased phosphatidylserine and diacylglycerol dependent 
phosphorylation f specific proteins was observed in nu- 
clei from PMA treated cells. We reasoned that if this 
increase in phosphorylation is due to translocation of PKC 
to the nucleus then the addition of exogenous PKC to 
nuclei isolated from untreated cells should yield a similar 
pattern of protein phosphorylation. As shown in Fig. 3C 
this is what we found. Several nuclear proteins have been 
shown to be phosphorylated by PKC in vitro, e.g. histone, 
topoisomerases [42,43] and nuclear lamins [21,22,44,45]. 
Using lamin specific antisera we have demonstrated that 
the increased phosphorylation of specific proteins which 
we observe on PKC stimulation may include phosphoryla- 
tion of lamin B as shown by the location of the arrowhead 
in Fig. 3C. Our data suggesting PKC mediated phosphory- 
lation of lamin B in MDCK cells is consistent with that 
shown in several other cell types (e.g., [21,22]). Lamin 
phosphorylation is a critical mediator of mitogenic disas- 
sembly of the nuclear lamina [46]. Previous work has 
suggested that the mitogenic effects of PKC might be 
attributable to lamin phosphorylation [11]. However, more 
detailed analysis has indicated that M-phase specific phos- 
phorylation of nuclear lamins occurs on alternative r sidues 
to those phosphorylated by PKC. Phosphorylation f lamin 
B by PKC has been proposed as a modulator of lamina 
structure which may have an important role controlling 
template activity of chromatin in transcription or replica- 
tion [47]. 
The phosphorylation data which we have presented 
suggest redistribution of PKC to the nuclear compartment 
on stimulation with phorbol esters. However the high 
endogenous phosphorylation activity suggests the possibil- 
ity of PKC location within the nucleus under basal condi- 
tions. We cannot preclude the possibility of the expression 
of PKC-LB in the nuclei of these cells. It has been 
reported that this isoform is expressed exclusively in the 
cell nucleus [48]. As it is activated by phorbol esters it is 
possible that the nuclear fluorescence of BODIPY-PMA 
which we observe may be due in part to binding to this 
form as well as to the [3 isoform. If PKC is localized 
within the nucleus under basal conditions this suggests a
novel hierarchy of signal transduction. Assuming that the 
recently described nuclear membrane associated phospholi- 
pase C [49,50] can provide diacylglycerol for activation of 
the kinase within the nucleus [51] one can only speculate 
as regards the nature of the ligand, receptor and transducer 
sequelae required for activation. One possibility is that 
ligand activated cell surface receptors may be internalized 
and activate nuclear phospholipase by their tyrosine kinase 
activity or by downstream unidentified tyrosine kinases. 
This may in turn initiate nuclear phospholipid hydrolysis, 
diacylglycerol production and release of nuclear calcium 
from an IP 3 sensitive pool [52,53] and subsequent PKC 
activation. This is a potential mechanism whereby agents 
coupled through similar second messengers may achieve 
selectivity; e.g., both IGF-1 and bombesin stimulate phos- 
pholipase activation in fibroblasts. The mitogenic stimulus 
IGF-1 is specifically coupled to nuclear phospholipase 
activation whereas the effects of the non-mitogenic stimu- 
lus bombesin are restricted to activation of plasma mem- 
brane associated phospholipase activity [54]. 
In summary, we have demonstrated PKC distribution in 
living cells stimulated with phorbol ester. We have shown 
differential subcellular localization of PKC isoforms on 
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stimulation with PMA; PKC0t is found associated with the 
cell periphery whereas PKC[3 is found in the nucleus. The 
observed nuclear PKC appe~trs to be catalytically active as 
shown by phosphorylation f endogenous and exogenous 
substrates. 
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